Genetic Factors Linked to Severe COVID-19, Viral Infections in Children
By LabMedica International staff writers Posted on 29 Apr 2021 |

Image: Histopathology of the lung showing diffuse alveolar damage seen in patients who are infected with the COVID-19 virus (Photo courtesy of Sanjay Mukhopadhyay, MD)
Although children, in general, are thought to experience relatively mild infections with SARS-CoV-2, a subset of infected children do become very ill and develop a condition known as Multisystem Inflammatory Syndrome in Children (MIS-C).
As in adults, severe pediatric COVID-19 cases have been documented more frequently in children with conditions such as asthma, chronic lung disease, diabetes, immunosuppression, or other high-risk traits or conditions. Of more than 2,600 children in the USA diagnosed with MIS-C before early March of this year, some 60% were male and more than 65% came from Hispanic/Latino or African American groups.
A team of medical scientists working with the Children's Mercy Research Institute (Kansas City, MO, USA) investigated rare genetic variants in a growing pediatric patient cohort in an effort to understand susceptibility to severe COVID-19 or other viral infections. The team shared findings from a retrospective genomic analysis on data from the Genomic Answers for Kids (GA4K), an ongoing pediatric repository that plans to enroll some 30,000 children and their family members in the coming seven years. They collected a wide range of molecular data types for the cohort, including exome sequencing, short-read PCR-free genome sequencing, whole-genome bisulfite sequencing, single-cell genomic analyses, 10x Genomics linked read mapping, and long-read sequence data.
The investigators focused on TLR3- and IRF7-dependent type I interferon immunity genes, and identified nearly four dozen extremely rare variants in 37 GA4K participants, including three deceased patients and one individual who was carrying four very rare variants in the IRF7 gene. Around half of those patients had a history of recurrent infections, though the children had not been diagnosed with SARS-CoV-2 infections. The variants did not appear to be enriched in any one gene, and did not track with biological sex, metabolic phenotype, or with cases from the GA4K diagnostic cohort.
Isabelle Thiffault, PhD, the director of Translational Genetics and a co-author of the study, said, “Studies like these are expected to prove beneficial beyond COVID-19, since as many as 200 viruses are believed to cause respiratory infections. In a typical year, the average school age child experiences between six and 12 such infections, with acute respiratory infections accounting for up to one-fifth of acute hospital admissions in children.” The study was presented at the American College of Medical Genetics and Genomics annual clinical meeting held virtually between 13-16 April, 2021.
Related Links:
Children's Mercy Research Institute
As in adults, severe pediatric COVID-19 cases have been documented more frequently in children with conditions such as asthma, chronic lung disease, diabetes, immunosuppression, or other high-risk traits or conditions. Of more than 2,600 children in the USA diagnosed with MIS-C before early March of this year, some 60% were male and more than 65% came from Hispanic/Latino or African American groups.
A team of medical scientists working with the Children's Mercy Research Institute (Kansas City, MO, USA) investigated rare genetic variants in a growing pediatric patient cohort in an effort to understand susceptibility to severe COVID-19 or other viral infections. The team shared findings from a retrospective genomic analysis on data from the Genomic Answers for Kids (GA4K), an ongoing pediatric repository that plans to enroll some 30,000 children and their family members in the coming seven years. They collected a wide range of molecular data types for the cohort, including exome sequencing, short-read PCR-free genome sequencing, whole-genome bisulfite sequencing, single-cell genomic analyses, 10x Genomics linked read mapping, and long-read sequence data.
The investigators focused on TLR3- and IRF7-dependent type I interferon immunity genes, and identified nearly four dozen extremely rare variants in 37 GA4K participants, including three deceased patients and one individual who was carrying four very rare variants in the IRF7 gene. Around half of those patients had a history of recurrent infections, though the children had not been diagnosed with SARS-CoV-2 infections. The variants did not appear to be enriched in any one gene, and did not track with biological sex, metabolic phenotype, or with cases from the GA4K diagnostic cohort.
Isabelle Thiffault, PhD, the director of Translational Genetics and a co-author of the study, said, “Studies like these are expected to prove beneficial beyond COVID-19, since as many as 200 viruses are believed to cause respiratory infections. In a typical year, the average school age child experiences between six and 12 such infections, with acute respiratory infections accounting for up to one-fifth of acute hospital admissions in children.” The study was presented at the American College of Medical Genetics and Genomics annual clinical meeting held virtually between 13-16 April, 2021.
Related Links:
Children's Mercy Research Institute
Latest Microbiology News
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
- Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
- POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
- Rapid Diagnostic Test Slashes Sepsis Mortality by 39%
- Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection
- Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections
- Diagnostic Test Accurately Detects Colorectal Cancer by Identifying Microbial Signature in Gut Bacteria
- Rapid Bedside Test Predicts Sepsis with Over 90% Accuracy
- New Blood Test Detects Up to Five Infectious Diseases at POC
- Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment
Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
AI Tool Enhances Interpretation of Tissue Samples by Pathologists
Malignant melanoma, a form of skin cancer, is diagnosed by pathologists based on tissue samples. A crucial aspect of this process is estimating the presence of tumor-infiltrating lymphocytes (TILs), immune... Read more
AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease
Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Novel Fluorescent Probe Shows Potential in Precision Cancer Diagnostics and Fluorescence-Guided Surgery
Hepatocellular carcinoma (HCC), a common type of liver cancer, is difficult to diagnose early and accurately due to the limitations of current diagnostic methods. Glycans, carbohydrate structures present... Read moreTechnology
view channel
Low-Cost Biosensing Technology Detects Disease Biomarkers in Minutes
Rapid at-home tests for diseases like COVID-19 have become increasingly popular for their convenience, but they come with a major drawback: they are less sensitive than the tests performed in medical settings.... Read more
AI Tool Could Help Identify Specific Gut Bacterial Targets for Treatment of Diseases
The human body hosts trillions of bacteria, particularly in the gut, which have a significant role in digestion and various other aspects of health. These gut bacteria produce a variety of metabolites... Read moreIndustry
view channel
Quanterix Completes Acquisition of Akoya Biosciences
Quanterix Corporation (Billerica, MA, USA) has completed its previously announced acquisition of Akoya Biosciences (Marlborough, MA, USA), paving the way for the creation of the first integrated solution... Read more
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Lunit (Seoul, South Korea) and Microsoft (Redmond, WA, USA) have entered into a collaboration to accelerate the delivery of artificial intelligence (AI)-powered healthcare solutions. In conjunction with... Read more